$IOVA - On our trading list. Did you get in? Buyout seems imminent. Iovance jumps as cancelled conference call renews buyout speculationShares of Iovance Biotherapeutics moved higher after Jefferies analyst Biren Amin noted that the firm's conference call with management scheduled for March 25 was cancelled by the company. Bloomberg on February 25 reported that Iovance is exploring a sale and has held preliminary talks with potential buyers. Iovance is working with a financial adviser after receiving takeover interest, a source told Bloomberg. Investors seem to be speculating that Iovance's cancelled call may portend to a takeover. The stock in afternoon trading is up 21%, or $5.03, to $28.84. $IOVA, Iovance Biotherapeutics, Inc. / H1 Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so). Follow us/bookmark us and check back occasionally for additional articles or comments on our page... Wild Tiger Trading - start/main page